The estimated Net Worth of Christopher Berthoux is at least $4.2 Milhão dollars as of 17 February 2004. Christopher Berthoux owns over 14,966 units of Charles River Laboratories International stock worth over $4,159,281 and over the last 21 years Christopher sold CRL stock worth over $36,800.
Christopher has made over 2 trades of the Charles River Laboratories International stock since 2003, according to the Form 4 filled with the SEC. Most recently Christopher exercised 14,966 units of CRL stock worth $479,511 on 17 February 2004.
The largest trade Christopher's ever made was exercising 14,966 units of Charles River Laboratories International stock on 17 February 2004 worth over $479,511. On average, Christopher trades about 1,140 units every 14 days since 2003. As of 17 February 2004 Christopher still owns at least 21,485 units of Charles River Laboratories International stock.
You can see the complete history of Christopher Berthoux stock trades at the bottom of the page.
Christopher's mailing address filed with the SEC is , , , , .
Over the last 22 years, insiders at Charles River Laboratories International have traded over $220,588,205 worth of Charles River Laboratories International stock and bought 18,392 units worth $3,841,397 . The most active insiders traders include James C Foster, Richard F Wallman, eDavid P Johst. On average, Charles River Laboratories International executives and independent directors trade stock every 14 days with the average trade being worth of $2,223,188. The most recent stock trade was executed by Joseph W La Plume on 8 August 2024, trading 1,780 units of CRL stock currently worth $354,861.
charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro
Charles River Laboratories International executives and other stock owners filed with the SEC include: